USANA Health Sciences (USNA) Misses Q2 EPS by 11c, provides guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $21.51 -0.97%
Revenue Growth %: +0.0%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
CRMT, More
Revenue Growth %: +0.0%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.54, $0.11 worse than the analyst estimate of $0.65. Revenue for the quarter came in at $213 million versus the consensus estimate of $221.01 million.
GUIDANCE:
USANA Health Sciences sees FY2024 EPS of $2.40-$2.55, versus the consensus of $2.77. USANA Health Sciences sees FY2024 revenue of $850-880 million, versus the consensus of $883.5 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
